Advertisement

Topics

Complement Genomics Company Profile

16:45 EST 18th November 2017 | BioPortfolio

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily
accessible and are located in Sunderland which is not too far away from all the local major
areas including Durham, Newcastle, Middlesbrough, Hartlepool, Leeds, York, Harrogate,
Carlisle, Darlington, Doncaster and Hexham.

Contact

Phone: 44 (0)191 5166500
Email: sales@dadcheck.com


News Articles [368 Associated News Articles listed on BioPortfolio]

Recognitions for Contributions in Genomics by Dan David Prize Awards

Recognitions for Contributions in Genomics by Dan David Prize Awards Reporter: Aviva Lev-Ari, PhD, RN   The Source for this List is a Search for “Genomics” on the Dan David Prize webs...

FILM: What Next for Genomics?

This film documents the Progress Educational Trust/Genomics England event 'What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS', which launched the Chief Medical Officer's ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Pricing of $2.73 Million Financing

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / August 4, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and ac...

Achillion Keeps Focus On Complement Factor D Inhibitors As J&J Exits HCV

J&J's decision to stop HCV development and end its partnership with Achillion has a ripple effect for the smaller biotech's...   

Famed Genomics Pioneer's Synthetic Genomics Hit With Gender Discrimination Lawsuit by Former VP

  Life Sciences Jobs   ...

Combination Of BioNano Genomics And 10X Genomics Data Produces High Quality Mammalian Genome At Low Cost

  Life Sciences Jobs   ...

Baheal Group will bring IBM’s Watson for genomics to China

IBM Watson Health announced that Baheal Pharmaceutical Group will bring Watson for Genomics to clinicians across China. As IBM’s primary channel partner for Watson for Genomics in China, B...

genomics, robotics, sample preparation, biotechnology, automated dilution, HTS

Provider,of,symposiums,for,bioinformatics,genomics,robotics,pharmacology,toxicology

Drugs and Medications [0 Results]

None

PubMed Articles [241 Associated PubMed Articles listed on BioPortfolio]

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.

Complement may play a key role in antibody-mediated rejection. A promising therapeutic approach may be classical pathway (CP) inhibition at the level of early component C1.

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.

Complement may play a key role in antibody-mediated rejection (ABMR). A promising therapeutic approach may be classical pathway (CP) inhibition at the level of early component C1.

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Binding of human complement C1 sterase inhibitor to Leptospira spp.

Leptospirosis is an important zoonosis of global importance caused by bacteria Leptospira spp. Pathogenic Leptospira is resistant to Complement System killing while non-pathogenic Leptospira is rapidl...

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

Clinical Trials [98 Associated Clinical Trials listed on BioPortfolio]

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a Single Ascending Dose (SAD) and a Multiple Dose (MD) of the complement inhibitor AMY-101. A prospective, single-c...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Procedure Outcome Predictor (POP) Using the Complement Cascade

Current post-operative monitoring of patient recovery consists measuring two blood markers C-reactive protein (CRP) and White Blood Cell Count (WBC). However, these are slow to respond to ...

Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease

Atypical hemolytic uraemic syndrome is caused by defects in the regulating factors in the alternative pathway of the complement system. Triggering can cause an uncontrolled complement acti...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

Companies [404 Associated Companies listed on BioPortfolio]

Complement Genomics

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily accessible and are loc...

True North Therapeutics

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

True North Therapeutics, Inc.

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Complement Genomics" on BioPortfolio

We have published hundreds of Complement Genomics news stories on BioPortfolio along with dozens of Complement Genomics Clinical Trials and PubMed Articles about Complement Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Complement Genomics Companies in our database. You can also find out about relevant Complement Genomics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record